Index | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | GBP 430 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 11.95% |
Inception/ Listing Date | 17 October 2019 |
Distribution policy | Distributing |
Distribution frequency | Semi annually |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
Revision Company | Deloitte |
Fiscal Year End | 30 November |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Eli Lilly & Co. | 6.00% |
Novo Nordisk A/S | 5.62% |
Novartis AG | 4.69% |
AstraZeneca PLC | 4.14% |
Gilead Sciences, Inc. | 3.72% |
Vertex Pharmaceuticals, Inc. | 3.16% |
Elevance Health, Inc. | 3.11% |
Edwards Lifesciences Corp. | 3.01% |
McKesson | 2.98% |
Zoetis | 2.89% |
United States | 64.14% |
Switzerland | 9.46% |
Japan | 6.67% |
United Kingdom | 4.46% |
Other | 15.27% |
Health Care | 92.45% |
Consumer Discretionary | 0.25% |
Other | 7.30% |
YTD | +4.58% |
1 month | -0.70% |
3 months | -1.31% |
6 months | -6.00% |
1 year | -1.44% |
3 years | +16.88% |
5 years | +36.85% |
Since inception (MAX) | +56.06% |
2024 | -3.95% |
2023 | -1.73% |
2022 | +8.13% |
2021 | +21.34% |
Current dividend yield | 0.98% |
Dividends (last 12 months) | GBP 0.06 |
Period | Dividend in GBP | Dividend yield in % |
---|---|---|
1 Year | GBP 0.06 | 0.96% |
2024 | GBP 0.06 | 0.97% |
2023 | GBP 0.07 | 1.12% |
2022 | GBP 0.06 | 1.13% |
2021 | GBP 0.06 | 1.27% |
Volatility 1 year | 11.95% |
Volatility 3 years | 14.33% |
Volatility 5 years | 16.61% |
Return per risk 1 year | -0.12 |
Return per risk 3 years | 0.37 |
Return per risk 5 years | 0.39 |
Maximum drawdown 1 year | -11.63% |
Maximum drawdown 3 years | -13.73% |
Maximum drawdown 5 years | -18.39% |
Maximum drawdown since inception | -18.57% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
Borsa Italiana | EUR | WHCS | - - | - - | - |
gettex | EUR | CBUF | - - | - - | - |
Euronext Amsterdam | USD | WHCS | WHCS NA iNAVWHC1 | WHCS.AS | |
SIX Swiss Exchange | USD | WHCS | WHCS SE iNAVWHC1 | WHCS.S | |
XETRA | EUR | CBUF | CBUF GY iNAVWHC1 | WHCS.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) | 98 | 0.18% p.a. | Accumulating | Sampling |